Please login to the form below

Not currently logged in

sales models

This page shows the latest sales models news and features for those working in and with pharma, biotech and healthcare.

Choices, choices...

Choices, choices...

And just as different biological species make different choices, then different business models are characterised by the risk and return trade-offs they make. ... This is true not just between companies but also between different business models within

Latest news

  • La La Land? The myth of multichannel excellence La La Land? The myth of multichannel excellence

    representative-led sales models. ... Worse still, only 11% provide their sales force with an integrated customer database that bridges all channels - meaning omnichannel customer intelligence remains low.

  • Choose or lose Choose or lose

    In biology, peaks represent successful species and, in the life science industry, peaks represent successful business models. ... How is this relevant? Well, it implies that hybrid business models will fail and business models that represent clear

  • The Italian Job The Italian Job

    The Italian Job. Therapy efficacy and value-based reimbursement models. In my August column in this publication, I spoke about the need for establishing a mechanism that would allow stakeholders to

  • Dive in: gaining leadership in a therapeutic area Dive in: gaining leadership in a therapeutic area

    Therapeutic area leadership was once defined simply by who had the biggest and best drug for that condition; the level of 'leadership' could usually be measured by sales figures, but times ... sales and its top-selling cancer drugs (Rituxan/MabThera,

  • The lost art of selling The lost art of selling

    Let's start with the humble sales aid. In my opinion we used to be pretty good at these. ... Lesson one - Sales aids should be created by people who understand how to sell.

More from news
Approximately 4 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Up to $75m per product in sales milestones. On option exercise Denali and Takeda will share 50:50 development/commercialisation costs and share profits. ... Royalty monetisation, share purchase. 250. Agenus/HealthCare Royalty Partners. Royalties on sales

  • Choosing destiny Choosing destiny

    To allow for this, firms ranked alternative models in relative, not absolute, terms. ... Build. Low relative risk. Manage. Focus. Table 2: A portfolio comparison of business models.

  • Healthcare business and operating models redefined Healthcare business and operating models redefined

    They must realise the fundamental impact new business models will have on their organisations. ... These models represent potential strategies and direction that life science companies can take.

  • M&A is now vital to pharma - but it's vital to get it right M&A is now vital to pharma - but it's vital to get it right

    deals. Senior leaders will need to ensure agility in their operating models so that they can anticipate and respond to challenges ahead.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...